About Sage Bionetworks
Sage Bionetworks (www.sagebase.org) is a Seattle-based non-profit biomedical research organization dedicated to developing predictors of disease and accelerating health research through the creation of open systems, incentives, and standards. Sage Bionetworks was formed in 2009 and arose from Rosetta Inpharmatics, a wholly owned subsidiary of Merck & Co, Inc.
We believe that advances are best harnessed when individuals and groups can collaborate openly without the existing boundaries of function, role or institution. To make open medical science possible, Sage Bionetworks is working with others to build a big data information Commons for biomedicine that puts patients first, an open compute space (Synapse: www.synapse.org) where models can be co-evolved, and pilot projects that demonstrate the power of open science to accelerate our understanding of biology.
Using Synapse and working from the organization’s deep computational biology roots, Sage Bionetworks collaborates with pharmaceutical and academic partners and with public-private-precompetitive consortiums. A common objective of these collaborations is to generate and analyze large-scale health data and to make this data broadly available for research.
Sage Bionetwork’s projects are fragile first steps towards a vibrant information commons that enables data driven medicine to flourish. We are encouraging courageous early adopters to tackle a few audaciously large problems in health that could only be addressed by teams of teams working off each other’s insights. From failures as well as successes will come meaningful learning about which tools, incentives and approaches best enable open research and citizen involvement to give us all health.